基于专利分析的我国化学药产业发展研究

Research on the Development of Chemical Industry in China Based on Patent Analysis

摘要: 随着新型冠状病毒肺炎(COVID-19)的到来和蔓延，颠覆了人们的医疗卫生安全观。面对不停演变的新冠病毒，各国越来越重视医药产业的新兴战略地位，加上经济全球供应链遭遇逆流，对我国传统优势产品出口和向更高价值链延伸也带来了诸多挑战。本文基于专利分析，通过融合创新方法技术成熟度预测和多元统计分析法，对我国化学药产业中药品研发、制药技术、给药技术和药品监管四个方面的所呈现的特点，梳理其技术专利趋势、高价值专利选育和市场竞争格局等专利数据，为我国化学药产业提升技术创新能力与技术创新效率水平，形成国内分段互补、产业链合作与国际主导权争夺、价值链攀升的医药制造业新发展格局提供精准数据支撑。

Abstract: With the arrival and spread of COVID-19, people’s medical and health safety concept has been re-versed. Faced with the continuous evolution of the new coronavirus, countries pay more and more attention to the emerging strategic position of the pharmaceutical industry, coupled with the re-verse flow of the economic global supply chain, it also brings many challenges to the export of tra-ditional advantage products and the extension of higher value chain in China. Based on patent analysis, this paper integrates the technology maturity prediction of innovation methods and mul-tivariate statistical analysis to analyze the characteristics of drug research and development, pharmaceutical technology, drug delivery technology and drug supervision in China’s chemical pharmaceutical industry. It sorts out the patent data such as technology patent trend, high-value patent selection and market competition pattern, so as to provide accurate data support for China’s chemical pharmaceutical industry to improve the level of technological innovation ability and technological innovation efficiency, and form a new development pattern of pharmaceutical man-ufacturing industry with domestic segmented complementarity, industrial chain cooperation and international dominance competition, and value chain climbing.